Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2007-1-11
pubmed:abstractText
We tested a sequential combination regimen using cisplatin and vinorelbine (PVn) followed by docetaxel as first-line chemotherapy in a phase II clinical trial in metastatic breast cancer (MBC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0030-2414
pubmed:author
pubmed:copyrightInfo
Copyright 2006 S. Karger AG, Basel.
pubmed:issnType
Print
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
330-8
pubmed:meshHeading
pubmed-meshheading:17164589-Adult, pubmed-meshheading:17164589-Aged, pubmed-meshheading:17164589-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17164589-Breast Neoplasms, pubmed-meshheading:17164589-Cisplatin, pubmed-meshheading:17164589-Disease Progression, pubmed-meshheading:17164589-Disease-Free Survival, pubmed-meshheading:17164589-Drug Administration Schedule, pubmed-meshheading:17164589-Female, pubmed-meshheading:17164589-Fever, pubmed-meshheading:17164589-Follow-Up Studies, pubmed-meshheading:17164589-Humans, pubmed-meshheading:17164589-Kidney, pubmed-meshheading:17164589-Middle Aged, pubmed-meshheading:17164589-Neoplasm Staging, pubmed-meshheading:17164589-Neutropenia, pubmed-meshheading:17164589-Survival Analysis, pubmed-meshheading:17164589-Taxoids, pubmed-meshheading:17164589-Treatment Outcome, pubmed-meshheading:17164589-Vinblastine, pubmed-meshheading:17164589-Vomiting
pubmed:year
2006
pubmed:articleTitle
A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.
pubmed:affiliation
American University of Beirut Medical Center, Beirut, Lebanon. as04@aub.edu.lb
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II